Peppermint Oil for Hair Regrowth
Evidence Review created on 09/27/2026 using AI4L + evidence-mcp / Grok 4.7
Also known as: Mentha piperita Oil, Peppermint Essential Oil, Menthae piperitae aetheroleum
Motivation
Peppermint oil is the steam-distilled essential oil of peppermint, a mint hybrid grown for flavor and fragrance. Most people meet it in tea, candy, or oral gut products. A smaller use applies diluted oil to the scalp in the hope of thicker hair. For adults who already pay attention to aging and to small, practical experiments, the question is whether that scalp use has any real effect on hair, or only a cold sensation.
The cooling comes mostly from menthol. The same cooling is used on the forehead for tension headache. One mouse experiment found that diluted oil started new hair growth on resting skin, with thicker skin and more hair roots than untreated skin, and with more visible coverage than a common hair drug. Fragrance and digestive use are old. The hair observation is recent. One small human trial did not show more hairs than the carrier oil alone.
This review examines what the oil is, how menthol acts on nerves and muscle, what human and animal studies show for hair and for better-studied effects, and what is known about irritation, allergy, oral heartburn, quality, and how change would be judged.
Benefits - Risks - Protocol - Conclusion
Recommended Reading
High-level discussions of peppermint oil on the scalp for androgenetic alopecia (pattern hair loss), and of the oil’s actions in people, from a lecture and from narrative papers.
-
The Science of Healthy Hair, Hair Loss and How to Regrow Hair - Andrew Huberman
Names peppermint oil among scalp applications meant to increase blood flow to hair-making cells, and argues that those maneuvers alone do not robustly regrow hair.
-
An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil. - Bin Rubaian et al., 2024
A narrative review of androgenetic alopecia (pattern hair loss) that includes peppermint oil and keeps it separate from the larger rosemary literature.
-
Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia. - Dinkins et al., 2023
Reviews peppermint oil alongside other scalp oils used in Black communities and notes that the growth experiments are mostly in mice.
-
Irritable Bowel Syndrome (IBS) - Shayna Sandhaus & Carrie Decker
A Life Extension protocol reviews oral peppermint oil trials for gut symptoms, including dose and heartburn, and does not grade hair regrowth.
-
Peppermint Oil Promotes Hair Growth without Toxic Signs. - Oh et al., 2014
Reports the controlled mouse experiment of 3% peppermint oil on shaved skin, with coverage, follicle measures, and a growth-signal readout.
Priority-expert searches did not find a peppermint-oil hair piece from Rhonda Patrick, Peter Attia, Chris Kresser, or Lifespan.io. Those sources discuss hair loss or peppermint in other contexts, so they are not listed. Life Extension’s oral-oil protocol is listed above.
Grokipedia
Peppermint oil for hair growth
Collects the 2014 mouse hair result, the cooling and blood-flow idea, and the absence of a rigorous human trial of peppermint oil for regrowth.
Examine
Peppermint benefits, dosage, and side effects
Summarizes oral peppermint oil for gut spasm, a 10% forehead dose for tension headache, and heartburn if an oral dose releases early. Hair regrowth is not graded.
ConsumerLab
Peppermint Oil for Irritable Bowel Syndrome (IBS): Does It Work?
Sets older positive oral trials next to later trials that missed their goals, and lists reflux and heartburn. Hair is outside its scope.
Systematic Reviews
No systematic review of peppermint oil for hair growth was found; the papers below analyze the oil for gut symptoms, including antispasmodics (drugs that relax gut muscle), or searched botanicals for central centrifugal cicatricial alopecia (scarring hair loss), so a hair-regrowth estimate is unrepresented.
-
The Use of Natural Ingredients in the Treatment of Alopecias with an Emphasis on Central Centrifugal Cicatricial Alopecia: A Systematic Review. - Ezekwe et al., 2020
Searched natural ingredients, including peppermint oil, for central centrifugal cicatricial alopecia (scarring hair loss) and found no trials.
-
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. - Ingrosso et al., 2022
Ten oral trials (1030 adults) still favored peppermint oil for gut symptoms, with very low certainty and more adverse events. Not a hair review.
-
The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. - Alammar et al., 2019
Twelve oral trials (835 adults) favored peppermint oil for global gut symptoms and pain. Adverse events were not clearly higher. Not a hair review.
-
Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. - Khanna et al., 2014
Nine oral trials (726 adults) favored intestine-release oil for gut symptoms. Heartburn, called mild, was the common adverse event. Not about hair.
-
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. - Ford et al., 2008
Four early oral trials (392 adults) found fewer persistent gut symptoms with peppermint oil than with placebo. Hair outcomes were not studied.
Mechanism of Action
Peppermint (Mentha × piperita) oil is mostly menthol and menthone, per the Cosmetic Ingredient Review, an industry-sponsored panel (Nair, 2001). Menthol opens CMR1 (cold and menthol receptor 1), later called TRPM8 (transient receptor potential melastatin 8, a pore that opens in cool skin) (McKemy et al., 2002). On the forehead it has been tied to higher skin blood flow and, at about 10% in ethanol, to less experimental pain (Göbel et al., 1995).
In the gut, menthol relaxes smooth muscle by limiting calcium movement across the cell membrane (Grigoleit & Grigoleit, 2005). On mouse skin, 3% oil in jojoba moved resting hair follicles (the roots that grow hair) into a growth phase, with higher alkaline phosphatase (ALP, a marker of early growing follicles) and insulin-like growth factor-1 (IGF-1, a signal linked with thicker hair) than saline or jojoba (Oh et al., 2014). Cooling fits sensation and headache better than new hair, and this mouse regrowth is not hormone-driven follicle shrinkage.
Administered orally, menthol is hydroxylated by CYP2A6 (a liver enzyme that processes menthol) and cleared as menthol glucuronide (menthol joined to a sugar acid for excretion) in bile and urine (Chumpitazi et al., 2018). Plasma half-life is about 56 minutes after 100 mg of menthol, and no skin half-life was found. Skin uptake is not above gut uptake (Nair, 2001). The oil slows CYP3A4 (cytochrome P450 3A4, a liver enzyme that clears many drugs) in human liver samples (Dresser et al., 2002). Its selectivity is broad, not hair-specific.
Historical Context & Evolution
Peppermint (Mentha × piperita) is a hybrid of watermint (Mentha aquatica) and spearmint (Mentha spicata). Leaf oil, obtained by steam distillation, was used for centuries as a remedy for gastric discomfort, and later as a flavor and a fragrance (Chumpitazi et al., 2018). Cosmetic use as a scent and a skin-conditioning ingredient is described at low leave-on levels by the industry-sponsored Cosmetic Ingredient Review panel (Nair, 2001).
Hair entered later. Scalp applications that cool were already used on the idea that a cooling sensation meant more blood at the follicle. A mouse experiment then found that 3% oil moved resting skin into a growth phase, with thicker skin, more and deeper follicles, and a higher growth-signal readout, without a body-weight change (Oh et al., 2014). Those are the findings: coverage and tissue measures in mice, not a human hair count.
Gut research took another path. Oral capsule trials were pooled more than once. They still disagree about how sure the benefit is and how often heartburn appears. Hair research did not build a matching series of positive human trials. No guideline in the sources reviewed endorses peppermint oil for hair. One small trial in young women did not show more hairs than coconut oil alone (Malarvizhi et al., 2025). The mouse result remains a mouse result. What changed is the gap: fragrance use, headache application, and gut trials are larger human observations, while the positive growth finding is still from mice.
Expected Benefits
High 🟩 🟩 🟩
Gut symptom relief ⚠️ Conflicted ⭕️ Not Central to Hair Regrowth
Oral peppermint oil is pooled in IBS trials. Ten trials (1030 people) found a relative risk (RR, how many times as likely) of not improving of 0.65, 95% confidence interval (CI, the likely range) 0.43–0.98, with very low certainty and more adverse events (Ingrosso et al., 2022). An earlier pool agreed on benefit but not on extra adverse events (Alammar et al., 2019). The net reading is that gut relief still shows in pools, while newer negative trials leave it unsettled and off the hair question.
Magnitude: RR of global symptoms not improving 0.65 (95% CI 0.43–0.98); number needed to treat (NNT, people per extra success) 4, in 10 oral trials (1030 people).
Less functional dyspepsia ⭕️ Not Central to Hair Regrowth (upper-abdominal discomfort after meals)
A review limited to randomized trials reports that placebo-controlled studies support oral peppermint oil for functional dyspepsia (upper-abdominal discomfort after meals). No pooled effect size is stated. This is a gut complaint, not a hair count (Chumpitazi et al., 2018).
Magnitude: Symptom relief is the reported direction in those placebo-controlled trials. The review states no single outcome figure for this indication.
Less abdominal pain in children ⭕️ Not Central to Hair Regrowth
That review also reports placebo-controlled support for oral peppermint oil in functional abdominal pain (belly pain without a structural cause) in children. No pooled effect size is given. The population is pediatric, not an adult scalp (Chumpitazi et al., 2018).
Magnitude: Less abdominal pain is the reported direction in those pediatric trials. The review states no single outcome figure.
Easier endoscopy ⭕️ Not Central to Hair Regrowth
Procedural studies have used the oil to relax gut muscle so colonoscopy and bile-duct endoscopy can be finished. A review summarizes those studies as successful for completing the procedure. That aid is not a hair outcome (Chumpitazi et al., 2018).
Magnitude: Procedure completion is the reported direction in the summarized studies. The review states no single success rate.
Less menstrual pain ⭕️ Not Central to Hair Regrowth
A systematic review of five randomized trials (499 people) found less menstrual pain with peppermint, including oil capsules in some trials, and called for higher-quality trials (Lagzian et al., 2025). Two trials were rated low quality. The outcome is menstrual pain, not a hair count.
Magnitude: Pain severity fell in those trials. The review states no single outcome figure.
Less nausea when oil is inhaled ⭕️ Not Central to Hair Regrowth
Inhaled peppermint oil was pooled across 19 randomized trials of nausea after surgery, in pregnancy, and after chemotherapy (Gergő et al., 2025). Nausea scores fell in each setting. This is nausea, not a hair count.
Magnitude: After surgery, nausea severity fell by 0.60 points (95% CI −0.77 to −0.44) at 2–6 hours in three trials. Larger drops were reported after chemotherapy.
Medium 🟩 🟩
Less chronic itch ⭕️ Not Central to Hair Regrowth
Fifty adults with itch from liver, kidney, or diabetes disease were split evenly. One group applied 5% peppermint oil in petrolatum twice daily for 2 weeks after hydrating the skin; the other applied petrolatum. The five-domain itch score (5-D) fell from 15.18 to 7.94 with the oil, versus 14.54 to 13.47 with petrolatum. This is itch, not a hair count (Elsaie et al., 2016).
Magnitude: 5-D itch total fell from 15.18 ± 3.55 to 7.94 ± 3.28 with 5% oil, versus 14.54 ± 2.09 to 13.47 ± 3.73 with petrolatum, over 2 weeks in 50 adults.
Less tension headache ⭕️ Not Central to Hair Regrowth
In 41 adults with tension-type headache, 10% peppermint oil in ethanol was spread on the forehead and temples at the start of an attack and again at 15 and 30 minutes. Across 164 attacks in a crossover, headache intensity fell more than with placebo by 15 minutes and stayed lower for an hour, with no clear difference from 1,000 mg of acetaminophen (a common pain medicine). No adverse events were reported. This is forehead pain, not a hair count (Göbel et al., 1996).
Magnitude: Headache intensity fell more than placebo by 15 minutes and through 60 minutes after 10% oil on the forehead, with no clear difference from 1,000 mg of acetaminophen. The abstract states no single score change.
Lower experimental headache sensitivity ⭕️ Not Central to Hair Regrowth
In 32 healthy adults, preparations were applied to the forehead and temples in a crossover. About 10% peppermint oil in ethanol reduced sensitivity to experimental headache pain. A peppermint-plus-eucalyptus mix did not show that pain effect. The paper also states that local peppermint oil raises forehead skin blood flow. This is a pain model, not a hair outcome (Göbel et al., 1995).
Magnitude: Experimental headache sensitivity fell after about 10% peppermint oil in ethanol. The abstract does not give the size of that drop.
Low 🟩
Speculative 🟨
Earlier growth phase in mouse skin
Male mice on 3% oil had about 92% coverage at week 4, versus about 55% with minoxidil (a scalp drug for pattern hair loss). The model was shaved resting skin (Oh et al., 2014).
Benefit-Modifying Factors
-
Genetics: No gene variant, including variation in the cold-sensing channel, has been shown to change any hair response to peppermint oil.
-
Baseline state: The mouse follicles were shaved into a resting phase. Pattern hair loss, with hormone-driven shrinkage, was not the model, so the same shift may not occur.
-
Baseline biomarkers: No blood marker, including iron or thyroid hormone, has been shown to change a hair response to this oil. The mouse experiment did not measure one.
-
Sex: The hair experiment used male mice only. No human hair study compared women and men.
-
Existing scalp disease: Inflamed, broken, or already allergic skin is where sensitization (becoming allergic after contact) is described, which can stop use before any hair change.
-
Age: No hair study enrolled older adults. Six-week-old mice do not represent thinner, older scalp skin.
Potential Risks & Side Effects
High 🟥 🟥 🟥
Heartburn after oral use ⚠️ Conflicted
Heartburn is the adverse event named most often after oral peppermint oil, and it is called mild and brief (Khanna et al., 2014). The trials used oral capsules, not a scalp film. Pools of any adverse event do not agree: one found more events on the oil (Ingrosso et al., 2022) and an earlier pool did not (Alammar et al., 2019). The net reading is that mild heartburn is named most often after oral capsules, while pools still disagree on whether adverse events increase.
Magnitude: Heartburn is the adverse event named most often after oral capsules, and it is called mild and brief. The cited reviews state no single heartburn rate.
Medium 🟥 🟥
No risk reaches Medium: the replicated human adverse-event finding is oral heartburn, already grouped under High, and skin reactions are uncontrolled case series.
Low 🟥
Allergic contact dermatitis (a rash from contact with an allergen)
Patch tests found menthol or peppermint sensitivity in 12 dental patients with mouth symptoms (Morton et al., 1995). Four others had lip dermatitis from peppermint oil in a balm (Tran et al., 2010). Isolated cases are noted, yet 8% oil did not sensitize in one allergy test (Nair, 2001).
Magnitude: Reactions are documented in selected patients with mouth or lip symptoms. No rate is reported for the general population or for diluted scalp use.
Skin burning or irritation
Rabbit skin injected with the oil showed moderate to severe reactions, without light-triggered toxicity (Nair, 2001). Human irritation is described only as isolated cases. Usual cosmetic leave-on use was 0.2% or less, far below undiluted oil.
Magnitude: Not quantified in available studies. No trial reports an irritation rate for diluted oil on the scalp.
Speculative 🟨
Liver stress if oil rich in a trace toxin is administered orally
Pulegone (a liver-toxic mint constituent) is capped at 1% in cosmetic oil. Rat studies, not human scalp series, are the basis (Nair, 2001).
Risk-Modifying Factors
-
Genetics: No variant has been tied to scalp irritation or allergy from this oil. Effects of CYP3A4 variation on a topical dose are untested.
-
Baseline skin: Application on impaired skin is the setting linked to sensitization, so a broken barrier raises the dermatitis risk.
-
Baseline labs: No blood marker has been tied to more irritation or allergy from this oil. Liver enzymes were not tested after a scalp film.
-
Sex: The lip and mouth case series do not establish a sex difference, and the oral adverse-event pools do not report one in the abstracts used.
-
Reflux and allergy: Existing heartburn matters if any oil is administered orally. A known peppermint or menthol allergy matters for skin contact.
-
Age: No scalp trial defines an older-adult irritation rate. Thinner aged skin can sting at a strength that younger skin tolerates. Pediatric hair trials were not found.
Key Interactions & Contraindications
-
Oral felodipine (a calcium-channel blocker, a drug that relaxes blood vessels): Caution. In 12 adults, 600 mg of oil raised exposure to 140% of water (range 77–262%), which can increase flushing or headache. Scalp use was not tested (Dresser et al., 2002).
-
Other CYP3A4-cleared drugs (simvastatin, cyclosporine): Caution. Slower clearance in human liver samples could raise exposure and side effects. No clinical change besides felodipine was shown, and scalp use was not tested.
-
Proton-pump inhibitors (omeprazole; acid-pump blockers) and H2 blockers (famotidine; histamine blockers that lower stomach acid): Caution. They can dissolve an enteric coating (a shell meant to open in the intestine) and raise heartburn. Avoid them with oral capsules. Scalp use was not tested.
-
Antacids (calcium carbonate): Caution. An antacid taken with an enteric-coated capsule can dissolve the coating early and cause heartburn. Separate the antacid by about 2 hours. Scalp use does not involve that capsule.
-
Other leave-on scalp drugs, including minoxidil: Caution. Menthol can increase skin penetration of other ingredients. The effect on minoxidil uptake is unmeasured. Mixing them in one bottle is untested (Nair, 2001).
-
Other topical menthol products: Caution. Cooling and irritation can add. Separate applications in time if both are used.
-
Oral oil when reflux is already present: Caution. Muscle relaxation in the gut can worsen heartburn. Scalp use does not require an oral dose; oil on the lips is a separate exposure.
Populations who should avoid Peppermint Oil:
- Known allergy to peppermint oil or menthol: further skin contact is an absolute contraindication because it can reproduce allergic dermatitis.
- Broken, weeping, or actively eczematous (eczema, a weepy itchy rash) scalp: caution, because impaired skin is where sensitization has been described.
- Preparations with pulegone above 1% if any oil may be administered orally: avoid; that is the cosmetic safety limit cited for liver toxicity.
- Direct contact with eyes or mouth lining: avoid; burning is the expected consequence, and no mitigation short of keeping oil off those surfaces is described.
- Liver disease, gallstones, or bile-duct obstruction, if any oil is administered orally: avoid; oral oil increases bile flow, and these conditions are listed as reasons not to use it.
- Infants and children under 2 years, and any child if oil is applied to the face or near the nose: avoid; menthol can interrupt breathing.
Risk Mitigation Strategies
-
Dilute before skin contact: The mouse hair dose was 3% in jojoba; usual cosmetic leave-on use was 0.2% or less. Dilution lowers burn and irritation.
-
Patch test a small area: A small amount left for 24–48 hours before wider use is how allergic dermatitis shows up early.
-
Keep oil out of eyes and off broken skin: That prevents chemical burn and lowers the sensitization setting described in case series.
-
Oral dosing is a different exposure: Oral capsules, not a scalp film, produced heartburn and the felodipine interaction at 600 mg.
-
Wash off at the first rash: Dermatitis is the stop signal. No taper is described, and reapplication continues the risk.
Therapeutic Protocol
-
One-month massage trial: Peppermint oil in coconut oil was massaged for 2–3 minutes, 3 days a week, for 1 month; hair count did not differ from coconut oil (Malarvizhi et al., 2025).
-
Mouse dose, not a human plan: 3% oil in jojoba, 100 microliters, once daily, 6 days a week, for 4 weeks, in male mice (Oh et al., 2014).
-
Cosmetic leave-on level is lower: The industry review described usual leave-on use at 0.2% or less and rinse-off use at 3% or less. Those are fragrance levels, not hair-growth doses (Nair, 2001).
-
Forehead tension-headache pattern: 10% oil in ethanol was spread on the forehead and temples at onset and again at 15 and 30 minutes in a headache trial, not a hair regimen (Göbel et al., 1996).
-
Time of day: No hair study compared morning with evening. The odor is used as an alerting scent, so night application is untested for sleep.
-
Half-life and splitting: Plasma half-life is about 56 minutes after 100 mg of menthol; delayed-release capsules last longer (Chumpitazi et al., 2018). A skin half-life was not found. Mouse dosing was once daily; the itch trial was twice daily.
-
Genetics: No variant has been shown to justify a different scalp strength.
-
Sex: The mouse hair study used males only. No human comparison supports a different dose for women or men.
-
Age: No older-adult hair protocol exists. The same percentage may sting more on thinner skin.
-
Baseline hair state: Response is untested in pattern hair loss. The mouse follicles were resting because they were shaved, not because of hormones.
-
Baseline biomarkers: No blood marker, including iron or thyroid hormone, has been shown to change the scalp response, so none sets a different strength.
-
Scalp condition: Inflamed or broken skin is a poor start, because that is the setting tied to sensitization.
Discontinuation & Cycling
-
Course length: Nothing shows that scalp use must continue for life. The mouse exposure lasted 4 weeks, and the oral gut trials were also short.
-
Withdrawal: No withdrawal syndrome is described after topical or oral peppermint oil in the trials reviewed.
-
Taper: No taper schedule exists. At a rash, the described action is to wash the oil off and stop.
-
Cycling: Schedules that stop and restart the oil to preserve an effect have not been studied.
Sourcing and Quality
-
Identity: Steam-distilled oil of Mentha piperita leaf is the identity to match, not an alcohol extract and not a perfume labeled only as mint.
-
Constituents: A matching oil is mostly menthol and menthone, with pulegone at or below 1%, the limit in the industry safety review (Nair, 2001).
-
Carrier: Jojoba was the diluent in the mouse hair experiment. That experiment did not put undiluted oil on skin.
-
Testing: A batch gas-chromatography report is the practical identity check. Open ConsumerLab pages reviewed lavender and tea tree, not a peppermint ranking.
-
Brands: No head-to-head purity test of scalp products was found, so no brand is singled out.
Practical Considerations
-
Time to effect: In mice, visible hair accelerated from week 2, with about 92% coverage at week 4. No human hair timeline is established.
-
Pitfalls: Using undiluted oil, reading a mouse resting-phase result as proof for pattern hair loss, and mixing this plant up with rosemary oil.
-
Regulatory status: Not approved as a hair-loss drug. The industry-sponsored cosmetic panel, whose sponsoring companies sell these products, called it safe as used when pulegone stays at or below 1% (Nair, 2001).
-
Cost and access: The oil is inexpensive and widely sold. Access is not the constraint. Human hair evidence is.
Interaction with Foundational Habits
-
Sleep: Direction: indirect. Peppermint odor is used as an alerting scent, and no trial measured sleep after scalp application. Night use could disturb some people through smell and cooling, by a sensory route rather than a sleep hormone.
-
Nutrition: Direction: none for a scalp film. Oil administered orally relaxes gut muscle and can worsen reflux around meals. No vitamin depletion was identified in the sources reviewed.
-
Exercise: Direction: none on training adaptation. Sweat may sting freshly oiled skin or thin the film. No study timed application around workouts.
-
Stress management: Direction: none. No study measured a stress hormone or a stress score after scalp peppermint oil. Cooling is a sensation, not a shown stress effect.
Monitoring Protocol & Defining Success
Before extended scalp use, standardized photos, a shed count, and a skin check are the baseline. The photos use the same light, distance, and part. Blood tests are not required by the oil. Iron, thyroid, or vitamin D labs belong to a general hair-loss work-up, not to a toxicity screen, and peppermint data set no target for them.
Ongoing checks sit at 2 weeks, 4 weeks, and then every 3 months if use continues. Two weeks is when mouse skin had already changed and when a human itch trial ended, so it is a first look for irritation. Four weeks matches the end of the mouse experiment. Later photos show whether density is changing at all. Stop rules are clinical: a new rash, eye pain, or a clear rise in shedding. Nothing in the oil’s record defines a blood schedule.
| Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes |
|---|---|---|---|
| Standardized scalp photos | No established target; track change from the individual’s own baseline | Shows whether coverage changes | Same light, distance, and part; before use, then at the timepoints above |
| Shed-hair count | No established target; track change from the individual’s own baseline | A simple check on shedding | Same combing routine each time; not a laboratory assay |
| Visible skin reaction | No established target; any new rash is a stop signal | Catches irritation or allergy | Inspect the day after the first applications and at each photo visit |
Qualitative markers:
- Cooling or burning in the first minutes after application
- Itch on the scalp, separate from ordinary dryness
- Whether the hair shaft feels coated or brittle
- Eye sting, which means oil has moved off the scalp
- A personal sense of thicker coverage, checked against the photos rather than instead of them
Emerging Research
-
No registered hair trial: A ClinicalTrials.gov search on 27 September 2026 for peppermint with alopecia or hair loss found no study of this oil for hair. Hits that matched nearby words were not peppermint oil for regrowth.
-
A larger trial could still go either way: One 2025 trial of peppermint oil in coconut oil did not beat coconut oil on hair count in 60 young women (Malarvizhi et al., 2025). A comparison with minoxidil could still support or erase the mouse lead (Oh et al., 2014).
-
Mixtures muddy the signal: A 2025 mouse study combined mastic gum with peppermint extract, not peppermint oil alone (Ham et al., 2025). Comparing the oil with that blend would show whether peppermint is the active part.
Conclusion
Peppermint oil is a mint essential oil rich in menthol, long used as a flavor, a fragrance, and an oral remedy for stomach discomfort, and only thinly studied on the scalp. For hair, one mouse experiment found that diluted oil started new hair growth on resting skin and gave more visible coverage than a standard hair drug. That is animal work. One small trial in young women did not show more hairs than coconut oil alone. Oral trials together disagree about short-term gut relief. Separate comparison trials report less upper-abdominal discomfort, less nausea when the oil is inhaled, including after surgery, less abdominal pain in children, less menstrual pain, and less tension headache after diluted oil is applied to the forehead. Those gut and headache findings are not about hair.
The repeating risks are heartburn when the oil is administered orally, and skin irritation plus allergy in case reports rather than in a counted scalp rate. An industry-sponsored cosmetic panel, funded by companies that sell these products, treats usual amounts left on skin as acceptable when a liver-toxic trace constituent stays low. A large oral dose can raise the level of at least one blood-pressure drug. The hair finding remains an animal experiment.
For adults who already track their own health, the oil is easy to obtain and the uncertainty is the record. Cooling, forehead blood flow, and mouse tissue findings are observed. A change in human hair density is not. Gut results do not carry over to the scalp.